A Dose Reduction Trial of Long-Acting Injectable Second-Generation Antipsychotics in Stable Schizophrenia
Not Applicable
Recruiting
- Conditions
- Schizophrenia, Schizoaffective disorder
- Registration Number
- JPRN-UMIN000037282
- Lead Sponsor
- Keio University School of Medicine Department of Neuropsychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Having a history of obvious harm to him/herself and/or others (2) Having significant physical or neurological illnesses (3) Having a diagnose of mental and behavioral disorders due to psychoactive substance use according to ICD-10 (4) Being pregnant or lactating (5) Having been judged as unable to provide informed consent by a person who explains the study (6) Being prohibited to receive reimbursement (in cases such as receiving public assistance and being prohibited from receiving reimbursement by the public assistance case worker) (7) Having been judged as unsuitable for the study for other reasons by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Brief Assessment of Cognition in Schizophrenia (BACS) composite scores from week 0 to week 24
- Secondary Outcome Measures
Name Time Method